MedPath

The effect of birch pollen immunotherapy on hazelnut allergy.

Completed
Conditions
Patients with birch pollen allergy and related hazelnut allergy.
Registration Number
NL-OMON26371
Lead Sponsor
ALK-ABELLO, Nieuwegein, The Netherlands
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
19
Inclusion Criteria

Patients >18 years with birch pollen allergy and hazelnut allergy.

Exclusion Criteria

1. Pregnancy;

2. significant concurrent disease;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DBPCFC with hazelnut before immunotherapy with birch pollen and after 1 year.
Secondary Outcome Measures
NameTimeMethod
Skin prick tests and serological analyses.
© Copyright 2025. All Rights Reserved by MedPath